Ageing contributes to phenotype transition in a mouse model of periodic paralysis

Periodic paralysis (PP) is a rare genetic disorder in which ion channel mutation causes episodic paralysis in association with hyper‐ or hypokalaemia. An unexplained but consistent feature of PP is that a phenotype transition occurs around the age of 40, in which the severity of potassium‐induced muscle weakness declines but onset of fixed, progressive weakness is reported. This phenotype transition coincides with the age at which muscle mass and optimal motor function start to decline in healthy individuals. We sought to determine if the phenotype transition in PP is linked to the normal ageing phenotype transition and to explore the mechanisms involved.

[1]  Zuneng Lu,et al.  SCN4A p.R675Q Mutation Leading to Normokalemic Periodic Paralysis: A Family Report and Literature Review , 2019, Front. Neurol..

[2]  D. Glass,et al.  Age-Related Gene Expression Signature in Rats Demonstrate Early, Late, and Linear Transcriptional Changes from Multiple Tissues. , 2019, Cell reports.

[3]  R. Phadke Myopathology of Congenital Myopathies: Bridging the Old and the New. , 2019, Seminars in pediatric neurology.

[4]  S. Jakob,et al.  Muscle membrane properties in A pig sepsis model: Effect of norepinephrine , 2018, Muscle & nerve.

[5]  W. Z'Graggen,et al.  In vivo assessment of muscle membrane properties in the sodium channel myotonias , 2018, Muscle & nerve.

[6]  Jacqueline A Palace,et al.  Atypical periodic paralysis and myalgia , 2018, Neurology.

[7]  S. Anker,et al.  Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017 , 2017, Journal of cachexia, sarcopenia and muscle.

[8]  J. Schott The neurology of ageing: what is normal? , 2017, Practical Neurology.

[9]  Robert B. White,et al.  Erratum to: Voluntary resistance wheel exercise from mid-life prevents sarcopenia and increases markers of mitochondrial function and autophagy in muscles of old male and female C57BL/6J mice , 2017, Skeletal Muscle.

[10]  F. Lehmann-Horn,et al.  Successful treatment of periodic paralysis with coenzyme Q10: two case reports , 2016, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[11]  B. Mittendorfer,et al.  Sexual dimorphism in skeletal muscle protein turnover. , 2016, Journal of applied physiology.

[12]  M. McKenna,et al.  Ca2+ leakage out of the sarcoplasmic reticulum is increased in type I skeletal muscle fibres in aged humans , 2016, The Journal of physiology.

[13]  L. Hayward,et al.  Understanding the physiology of the asymptomatic diaphragm of the M1592V hyperkalemic periodic paralysis mouse , 2015, The Journal of general physiology.

[14]  L. Hayward,et al.  Physiological basis for muscle stiffness and weakness in a knock‐in M1592V mouse model of hyperkalemic periodic paralysis , 2015, Physiological reports.

[15]  Young Han Lee,et al.  Whole-Body Muscle MRI in Patients with Hyperkalemic Periodic Paralysis Carrying the SCN4A Mutation T704M: Evidence for Chronic Progressive Myopathy with Selective Muscle Involvement , 2015, Journal of clinical neurology.

[16]  M. McKenna,et al.  Contractile properties and sarcoplasmic reticulum calcium content in type I and type II skeletal muscle fibres in active aged humans , 2015, The Journal of physiology.

[17]  M. Hanson,et al.  Potassium dependent rescue of a myopathy with core-like structures in mouse , 2015, eLife.

[18]  Steve D. M. Brown,et al.  Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis , 2014, Brain : a journal of neurology.

[19]  Wenjun Xie,et al.  Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging , 2014, Proceedings of the National Academy of Sciences.

[20]  M. Hanna,et al.  Muscle channelopathies: recent advances in genetics, pathophysiology and therapy. , 2014, Current opinion in neurology.

[21]  Ian J. Deary,et al.  Grip Strength across the Life Course: Normative Data from Twelve British Studies , 2014, PloS one.

[22]  L. Hayward,et al.  Contractile abnormalities of mouse muscles expressing hyperkalemic periodic paralysis mutant NaV1.4 channels do not correlate with Na+ influx or channel content. , 2014, Physiological genomics.

[23]  R. Howard,et al.  Chloride channels in myotonia congenita assessed by velocity recovery cycles , 2014, Muscle & nerve.

[24]  B. Picard,et al.  A Simplified Immunohistochemical Classification of Skeletal Muscle Fibres in Mouse , 2014, European journal of histochemistry : EJH.

[25]  S. Cannon,et al.  Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis. , 2013, Brain : a journal of neurology.

[26]  V. Drouin‐Garraud,et al.  Episodic weakness due to mitochondrial DNA MT-ATP6/8 mutations , 2013, Neurology.

[27]  F. Lehmann-Horn,et al.  Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals , 2013, Journal of Neurology.

[28]  S. Cannon,et al.  Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis , 2013, Neurology.

[29]  B. Luo,et al.  Gender differences in penetrance and phenotype in hypokalemic periodic paralysis , 2013, Muscle & nerve.

[30]  R. Howard,et al.  Membrane dysfunction in Andersen‐Tawil syndrome assessed by velocity recovery cycles , 2012, Muscle & nerve.

[31]  Dhaval P. Bhatt,et al.  A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[32]  T. Shiomi,et al.  Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. , 2011, Cell metabolism.

[33]  W. Z'Graggen,et al.  Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia , 2009, Muscle & nerve.

[34]  S. Cannon,et al.  Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness. , 2008, The Journal of clinical investigation.

[35]  W. Catterall,et al.  Gating pore current in an inherited ion channelopathy , 2007, Nature.

[36]  J. Miyazaki,et al.  Simultaneous gene transfer of bone morphogenetic protein (BMP) -2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression , 2006, BMC musculoskeletal disorders.

[37]  I. Kohane,et al.  Transcriptome-scale similarities between mouse and human skeletal muscles with normal and myopathic phenotypes , 2006, BMC musculoskeletal disorders.

[38]  Timothy A. Miller,et al.  Correlating phenotype and genotype in the periodic paralyses , 2004, Neurology.

[39]  P. Chinnery,et al.  Normokalemic periodic paralysis revisited: Does it exist? , 2002, Annals of neurology.

[40]  V. Pesce,et al.  Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle. , 2001, Free radical biology & medicine.

[41]  F. Lehmann-Horn,et al.  Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. , 2001, Brain : a journal of neurology.

[42]  G Sjøgaard,et al.  Dynamics and consequences of potassium shifts in skeletal muscle and heart during exercise. , 2000, Physiological reviews.

[43]  G. Rutter,et al.  Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Armstrong,et al.  E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions. , 1998, Journal of applied physiology.

[45]  G. Radda,et al.  Skeletal muscle metabolism in myotonic dystrophy A 31P magnetic resonance spectroscopy study. , 1997, Brain : a journal of neurology.

[46]  M. Messi,et al.  Dihydropyridine Receptor-Ryanodine Receptor Uncoupling in Aged Skeletal Muscle , 1997, The Journal of Membrane Biology.

[47]  M. Leppert,et al.  Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus. , 1991, American journal of human genetics.

[48]  S. Cannon,et al.  A sodium channel defect in hyperkalemic periodic paralysis: Potassium-induced failure of inactivation , 1991, Neuron.

[49]  M. Zwarts,et al.  Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects. , 1990, Brain : a journal of neurology.

[50]  P. Grafe,et al.  Adynamia episodica hereditaria with myotonia: A non‐inactivating sodium current and the effect of extracellular pH , 1987, Muscle & nerve.

[51]  W. Troni,et al.  Interictal conduction slowing in muscle fibers in hypokalemic periodic paralysis , 1983, Neurology.

[52]  A. Engel,et al.  Calcium activation of electrically inexcitable muscle fibers in primary hypokalemic periodic paralysis , 1969, Neurology.

[53]  G. Glaser,et al.  Resting potential and distribution of muscle fibers in living mammalian mucle. , 1961, American journal of physical medicine.

[54]  I. Gamstorp Adynamia Episodica Hereditaria , 1956, Acta genetica et statistica medica.